Physician

Mary J Gentine, M.D.

According to 2025 Medicare claims, Mary Gentine, M.D. (NPI: 1811945942) practices family practice in the Sheboygan, WI market, with the plurality of this provider's patient population coming from Sheboygan, WI. This provider's primary affiliated billing organization is FROEDTERT MANITOWOC MEDICAL GROUP, LLC (NPI: 1437829975; TIN: 871785388) and primary practice location at 53081-8432. Gentine is affiliated with the Froedtert & The Medical College of Wisconsin ACO, LLC (ACO ID: A4825), participating under the MSSP model.

Gentine's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,340 traditional Medicare patients, billed 4,671 HCPCS/CPT codes, and received $117,159 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 9,465 prescription claims across 778 beneficiaries totaling $567,918 in drug costs, led by Eliquis (Apixaban). DME data shows 138 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $411,140 to $567,918. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,529 and ending at $16,807.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	339	2,835	$89,698
2016	394	3,085	$71,099
2017	380	3,324	$79,405
2018	359	2,742	$89,079
2019	458	3,472	$93,624
2020	410	3,237	$93,771
2021	399	2,995	$100,265
2022	235	638	$52,882
2023	862	2,318	$87,160
2024	1,340	4,671	$117,159

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	493	8,531	$411,140
2016	563	9,104	$413,923
2017	579	8,595	$414,754
2018	615	9,008	$490,117
2019	732	9,917	$577,381
2020	755	11,372	$664,344
2021	826	10,906	$701,309
2022	792	8,142	$504,490
2023	643	7,043	$481,967
2024	778	9,465	$567,918

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	47	279	$11,511
2016	42	308	$8,855
2017	46	293	$6,746
2018	55	308	$8,800
2019	53	277	$9,942
2020	47	196	$6,134
2021	44	168	$3,995
2022	23	73	$1,589
2023	18	81	$3,650
2024	37	138	$6,534

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	221	221	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	255	374	$76
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	88	123	$11
36415	Insertion of needle into vein for collection of blood sample	1,272	3,241	$9
81003	Automated urinalysis test	126	171	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	118	5,929	$115,037
Trulicity	Dulaglutide	53	2,074	$70,994
Ozempic	Semaglutide	46	1,680	$52,701
Jardiance	Empagliflozin	23	1,574	$29,509
Xarelto	Rivaroxaban	17	1,110	$19,292

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	11	$4,873
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	26	63	$665
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	N/R	12	$420
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	14	$410
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	12	$143

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mary J. Gentine, M.D.?

Tedicare shows public-source Medicare data for Mary J. Gentine, M.D. (NPI 1811945942), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mary J. Gentine, M.D. have ACO affiliation data?

Mary J. Gentine, M.D. is shown with ACO affiliation data for Froedtert & The Medical College of Wisconsin ACO, LLC (MSSP, ACO ID A4825).

What billing organization is linked to Mary J. Gentine, M.D.?

Mary J. Gentine, M.D. is linked to FROEDTERT MANITOWOC MEDICAL GROUP, LLC (billing NPI 1437829975) in the available physician profile data.

Does Mary J. Gentine, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.